Replies to post #139959 on Biotech Values

[iwfal]

Does anyone care to comment on the alarming statistic in #msg-74094967 that 13% of China’s adult population has type-2 diabetes? The concern is not only the 13% figure per se, but also the apparently rapid increase from the estimate of 10% given a short time ago (#msg-48221898).

I'd suggest such epidemiological measurements are generally pretty noisy - especially so in light of the different definitions of diabetes (and changes in those definitions): FBG, HbA1c, OGTT, ... .

That said, I do expect that there will be significant growth in diabetes in China etc. Growth from 10 to 20+ pct in 15 years seems entirely plausible. But trying to measure a 3 pct difference across two different epi studies not performed to the same protocol seems not highly likely to be accurate.

[genisi]

Hypertension is also a growing epidemic in China and so is dyslipidemia.